Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients-Reference-Cited by-同舟云学术

Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients

Published:2008-07 Issue:1 Volume:248 Page:288-296
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Seror Olivier,N'Kontchou Gisèle,Ibraheem Medhat,Ajavon Yves,Barrucand Corinne,Ganne Nathalie,Coderc Emmanuelle,Claude Trinchet Jean,Beaugrand Michel,Sellier Nicolas

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2481071101

Reference20 articles.

1. Early-Stage Hepatocellular Carcinoma in Patients with Cirrhosis: Long-term Results of Percutaneous Image-guided Radiofrequency Ablation

2. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series

3. Hepatocellular Carcinoma: Radio-frequency Ablation of Medium and Large Lesions

4. Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Success as Defined by Histologic Examination of the Explanted Liver

5. Radiofrequency Ablation: In Vivo Comparison of Four Commercially Available Devices in Pig Livers

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of early and late hepatocellular carcinoma recurrence;World Journal of Gastroenterology;2023-02-28

2. Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis;Cancers;2022-05-26

3. The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization;Clinics and Research in Hepatology and Gastroenterology;2022-04

4. Percutaneous treatments of hepatocellular carcinoma: Improving efficacy, applicability and extending ablation criteria;Liver Cancer International;2022-01-13

5. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation;Cancer Biotherapy and Radiopharmaceuticals;2021-12-01